An increase in leptin and visfatin which reflect body fat mass, and a concomitant decrease in adiponectin level may contribute to the pathogenesis of obesity-linked metabolic and cardiovascular complications (11, 13–16). The gene discussed is LEP; the disease is obesity disorder.